Sorrento Therapeutics, Inc. → Scilex Holding Co SCLXW

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 16/100

Passive Schedule 13G filer baseline
Elevated short days-to-cover (26.5 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

1 transaction

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 26.51

178,361 shares short · +5.6% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-07-03	SCLX Stock Acquisition JV LLC	10%+ owner	J	500,000	—	—

Other 13D/G Filings on Scilex Holding Co

Filed	Form	Filer	Stake	Shares
2026-07-07	SCHEDULE 13D/A	SCLX Stock Acquisition JV LLC	—	30,029,378	view →
2025-01-23	SCHEDULE	SCLX Stock Acquisition JV LLC	21.10%	80,586,928	view →
2025-01-06	SCHEDULE	SCLX Stock Acquisition JV LLC	22.80%	84,616,299	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →